{"id":17066,"date":"2020-01-13T13:56:09","date_gmt":"2020-01-13T13:56:09","guid":{"rendered":"https:\/\/celonpharma.com\/?p=17066"},"modified":"2020-01-13T13:56:09","modified_gmt":"2020-01-13T13:56:09","slug":"celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/","title":{"rendered":"Celon Pharma S.A. at the JP Morgan Investor Conference 2020"},"content":{"rendered":"

This year’s conference will be held between 13 and 16 January 2020 in San Francisco. Representatives of the Company\u2019s Management Board will participate in the event.<\/span><\/p>\n

Maciej Wieczorek, CEO of Celon Pharma S.A.: This year, we are focusing on continuing the talks regarding a partnership agreement for esketamine DPI. The schedule of the phase II clinical trial does not currently affect the subject of the ongoing talks. In line with our strategy of global commercialisation of our innovation portfolio, in response to numerous questions and interest from investors, we are planning meetings concerning other projects in the field of neurology and metabolic diseases. <\/em><\/span><\/p><\/blockquote>\n

Annual meetings held as part of the JP Morgan Healthcare Conference are the largest event of its kind, bringing together investors, leaders and creators of modern technologies in the field of life science.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

This year’s conference will be held between 13 and 16 January 2020 in San Francisco. Representatives of the Company\u2019s Management Board will participate in the event. Maciej Wieczorek, CEO of Celon Pharma S.A.: This year, we are focusing on continuing the talks regarding a partnership agreement for esketamine DPI. The schedule of the phase IIRead more »<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-17066","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"\nCelon Pharma S.A. at the JP Morgan Investor Conference 2020 - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma S.A. at the JP Morgan Investor Conference 2020 - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"This year’s conference will be held between 13 and 16 January 2020 in San Francisco. Representatives of the Company\u2019s Management Board will participate in the event. Maciej Wieczorek, CEO of Celon Pharma S.A.: This year, we are focusing on continuing the talks regarding a partnership agreement for esketamine DPI. The schedule of the phase IIRead more »\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-13T13:56:09+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/\",\"url\":\"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/\",\"name\":\"Celon Pharma S.A. at the JP Morgan Investor Conference 2020 - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2020-01-13T13:56:09+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma S.A. at the JP Morgan Investor Conference 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma S.A. at the JP Morgan Investor Conference 2020 - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma S.A. at the JP Morgan Investor Conference 2020 - CelonGROUP","og_description":"This year’s conference will be held between 13 and 16 January 2020 in San Francisco. Representatives of the Company\u2019s Management Board will participate in the event. Maciej Wieczorek, CEO of Celon Pharma S.A.: This year, we are focusing on continuing the talks regarding a partnership agreement for esketamine DPI. The schedule of the phase IIRead more »","og_url":"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/","og_site_name":"CelonGROUP","article_published_time":"2020-01-13T13:56:09+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/","url":"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/","name":"Celon Pharma S.A. at the JP Morgan Investor Conference 2020 - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2020-01-13T13:56:09+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2020\/01\/13\/celon-pharma-s-a-at-the-jp-morgan-investor-conference-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma S.A. at the JP Morgan Investor Conference 2020"}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/17066","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=17066"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/17066\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=17066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=17066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=17066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}